Sabby Management’s Onconetix ONCO Stock Holding History

Sabby Management’s Portfolio ONCO Stock Details ONCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3	Closed	-$620K	–	118
2022 Q4	$620K	Hold	3	–	–	0.54%	22
2022 Q3	$944K	Sell	3 -1	-25%	-$438K	1.19%	20
2022 Q2	$1.3M	Buy	+4	New	+$5.5M	0.88%	20

Other funds holding ONCO

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Sabby Management's ONCO Position: Q1 2023 in Review

Sabby Management sold out of Onconetix (ONCO) in Q1 2023, closing a stake of 3 shares — an estimated $620K sold.

Sabby Management first reported a position in ONCO in Q2 2022 and held it in 3 quarters. The position peaked at $1.3M in Q2 2022. 3 funds tracked by Wall St. Rank hold ONCO as of Q1 2023.

Sabby Management reported no remaining Onconetix position as of Q1 2023 after selling out during the quarter.
Sabby Management sold 3 Onconetix shares in Q1 2023, an estimated $620K.
Sabby Management first reported a position in Onconetix in Q2 2022 and held it in 3 quarters.
Sabby Management's Onconetix position peaked at $1.3M in Q2 2022.
3 funds tracked by Wall St. Rank held Onconetix as of Q1 2023.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.